J44 C34
Conditions
Interventions
None listed
Sponsors
Institut für Palliative Care (ipac) e.V.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with the following criteria will be eligible for this study. The inclusion criteria will be: 1)diagnosis of advanced disease as defined as follows: Lung cancer: Primary lung cancer at all stages (small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)), cancer at any site with secondary tumour of the lung (lung metastasis); COPD: stage III or IV of the GOLD classification (Global Initiative for Obstructive Lung Disease), which include the airflow limitation measured by spirometry FEV1 < 50%, FEV1/FVC < 0.7 (FEV1: forced expiratory volume in one second; FVC: forced vital capacity) and symptoms such as more severe breathlessness, reduced exercise capacity and repeated exacerbations; 2)age = 18 years. Disease orientated therapies (chemotherapy, radiotherapy, surgery) can be ongoing.
Exclusion criteria
Exclusion criteria: (1) lack of capacity to give informant consent; (2) lack of capacity to be interviewed;(3)cognitive impairment (clinical judgment by the principal investigator)
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| symptoms and needs: Palliative Care Outcome Scale (POS); functional ability: Karnofsky Performance Scale (KPS); quality of life: EuroQoL5 (EQ-5D); health service use: number of hospital admissions, number of admissions to A&E; comorbidities: Charlson Comorbidity Index (CCI) | — |
Primary
| Measure | Time frame |
|---|---|
| Dyspnoea: modified Borg-Scale; episodic breathlessness: number of attacks, mean length of attack, severity of attack Time of measurement: every 4 weeks | — |
Countries
Germany
Contacts
Public ContactSteffen Simon
Institut für Palliative Care (ipac) e.V.
Outcome results
None listed